Status:

COMPLETED

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU

Lead Sponsor:

Emory University

Collaborating Sponsors:

Sanofi

Grady Health System

Conditions:

Diabetes or With New Hyperglycemia

Eligibility:

FEMALE

18-70 years

Phase:

NA

Brief Summary

The study is a multicenter, prospective, open-label randomized study to compare the safety and efficacy of continuous insulin infusion (CII) via a computer-guided(Glucommander) and a standard paper fo...

Detailed Description

Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Blood glucose control with intensive insu...

Eligibility Criteria

Inclusion

  • Males or females between the ages of 18 and 70 years admitted to a medical ICU
  • A known history of diabetes mellitus or with new hyperglycemia untreated or treated by diet, insulin therapy or with any combination of antidiabetic agents (sulfonylureas, metformin, thiazolidinediones).
  • Blood glucose greater than 120 mg/dl on ≥ 2 occasions for known, treated diabetics or greater than 140 mg/dl on ≥ 2 occasions for those with new hyperglycemia.
  • Subjects must have an admission blood glucose \< 400 mg/dL, without laboratory evidence of diabetic ketoacidosis (serum bicarbonate \< 18 milliequivalents/L or positive serum or urinary ketones).

Exclusion

  • Subjects with acute hyperglycemic crises such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state \[38\].
  • Patients with known HIV, severely impaired renal function (serum creatinine ≥3.0 mg/dl).
  • Patients with mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
  • Female subjects who are pregnant or breast feeding at time of enrollment into the study.

Key Trial Info

Start Date :

June 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00394524

Start Date

June 1 2006

End Date

September 1 2008

Last Update

October 30 2018

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Grady Memorial Hospital

Atlanta, Georgia, United States, 30303

2

Piedmont Hopsital

Atlanta, Georgia, United States, 30309

3

University of Tennessee Health Science Center, Memphis

Memphis, Tennessee, United States, 38103

4

University of Washington, Seattle

Seattle, Washington, United States, 98195